Quest Diagnostics Incorporated
DGXLast close · Oct 16, 2026235.00−4.15 (−1.74%)
Market cap$25.9B
Key indicators
Revenue11.6B+9.9% on a year earlier
7.5B
7.7B
9.4B
10.8B
9.9B
9.3B
9.9B
11.0B
11.6B
12.0B
12.6B
13.1B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 7.5B | 7.7B+2.6% | 9.4B+22.1% | 10.8B+14.3% | 9.9B−8.4% | 9.3B−6.4% | 9.9B+6.7% | 11.0B+11.8% | 11.6B+9.9% | 12.0B | 12.6B | 13.1B | |
| — | 2.6% | 22.1% | 14.3% | -8.4% | -6.4% | 6.7% | 11.8% | 9.9% | 8.9% | 4.6% | 4.3% | |
| $5.29 | $6.28+18.7% | $10.47+66.7% | $15.55+48.5% | $7.97−48.7% | $7.49−6.0% | $7.69+2.7% | $8.75+13.8% | $9.42+13.4% | $11.20 | $12.04 | $13.07 | |
| Profitability | ||||||||||||
| 34.6% | 34.8%+0.2 pt | 38.5%+3.7 pt | — | — | — | — | — | — | · | · | · | |
| 14.6% | 15.9%+1.3 pt | 20.9%+5.0 pt | 22.1%+1.2 pt | 14.4%−7.6 pt | 13.6%−0.8 pt | 13.6%−0.0 pt | 14.1%+0.5 pt | 14.1%+0.1 pt | · | · | · | |
| 9.8% | 11.1%+1.3 pt | 15.2%+4.1 pt | 18.5%+3.3 pt | 9.6%−8.9 pt | 9.2%−0.3 pt | 8.8%−0.4 pt | 9.0%+0.2 pt | 9.2%+0.2 pt | · | · | · | |
| 14.1% | 15.2%+1.1 pt | 21.2%+6.0 pt | 31.0%+9.8 pt | 16.1%−14.9 pt | 13.5%−2.5 pt | 12.9%−0.7 pt | 13.8%+1.0 pt | — | · | · | · | |
| Cash | ||||||||||||
| 817.0M | 843.0M+3.2% | 1.6B+88.3% | 1.8B+15.3% | 1.3B−28.2% | 864.0M−34.2% | 909.0M+5.2% | 1.4B+49.5% | 1.3B+10.2% | · | · | · | |
| 10.8% | 10.9%+0.1 pt | 16.8%+5.9 pt | 17.0%+0.1 pt | 13.3%−3.7 pt | 9.3%−4.0 pt | 9.2%−0.1 pt | 12.3%+3.1 pt | 11.7%+0.0 pt | · | · | · | |
| 266.0M | 286.0M+7.5% | 297.0M+3.8% | 309.0M+4.0% | 305.0M−1.3% | 314.0M+3.0% | 331.0M+5.4% | 353.0M+6.6% | — | · | · | · | |
| Balance sheet | ||||||||||||
| 0.75x | 0.85x+0.10x | 0.59x−0.25x | 0.62x+0.03x | 0.68x+0.05x | 0.75x+0.07x | 0.92x+0.17x | 0.79x−0.13x | 0.75x−0.03x | · | · | · | |
| 139.00M | 136.00M−2.2% | 136.00M+0.0% | 128.00M−5.9% | 118.00M−7.8% | 113.00M−4.2% | 113.00M+0.0% | 113.00M+0.0% | 112.00M−0.9% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.